Intelligent Radiopharmaceutical Composition Preparation and Monitoring System
Legal Citation
Summary of the Inventive Concept
A novel system integrating AI, IoT, and blockchain technologies to optimize and monitor radiopharmaceutical compositions, ensuring personalized medicine and improved patient outcomes.
Background and Problem Solved
The original patent provided a stable radiopharmaceutical composition of tetrofosmin, but its limitations included manual preparation, lack of real-time monitoring, and limited customization options. The new inventive concept addresses these limitations by incorporating advanced technologies to create a more efficient, secure, and patient-centric system.
Detailed Description of the Inventive Concept
The system comprises a blockchain-based platform for secure data storage and sharing, an AI-powered diagnostic tool for selecting optimal tetrofosmin concentrations, and an IoT-enabled lyophilization unit for automated kit preparation. Additionally, the system integrates pH and temperature sensors with AI-powered predictive analytics for real-time stability monitoring, and an RFID tag for tracking and authentication purposes. The system can also optimize radiopharmaceutical composition formulations using machine learning and 3D printing, and features a smart packaging system with sensor-enabled containers and blockchain-based tracking.
Novelty and Inventive Step
The new inventive concept's integration of AI, IoT, and blockchain technologies with the original patent's radiopharmaceutical composition provides a novel and non-obvious solution, overcoming the limitations of manual preparation, limited customization, and lack of real-time monitoring.
Alternative Embodiments and Variations
Alternative embodiments include using different AI algorithms for diagnostic tool optimization, incorporating additional sensors for real-time monitoring, and integrating the system with electronic health records for seamless data exchange. Variations of the system could be designed for specific disease indications, patient populations, or geographic regions.
Potential Commercial Applications and Market
The intelligent radiopharmaceutical composition preparation and monitoring system has significant commercial potential in the pharmaceutical, healthcare, and medical imaging industries, with potential applications in personalized medicine, disease diagnosis, and treatment monitoring.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K51/0478 |
| A | A61 | A61K9/19 |
| A | A61 | A61K31/66 |
| A | A61 | A61K51/025 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Radiopharmaceutical composition design and preparation, specifically involving technetium-99m labeled diagnostic agents, with expertise in pharmaceutical formulation, analytical chemistry, and medical imaging technologies
Person of Ordinary Skill (PHOSITA) Profile
A professional with advanced degrees in pharmaceutical sciences or nuclear pharmacy, familiar with radiopharmaceutical preparation techniques, stability optimization, quality control methods, and emerging technologies in medical diagnostics
Obviousness Rationale
A PHOSITA would recognize that integrating digital technologies like AI, IoT, and blockchain with existing radiopharmaceutical composition techniques represents a predictable application of known technological solutions to improve monitoring, preparation, and customization of diagnostic agents. The core radiopharmaceutical composition remains fundamentally consistent with the source patent, with technological enhancements representing incremental improvements in preparation and tracking methodologies.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,647 |
|---|---|
| Title | Pharmaceutical composition comprising tetrofosmin and pharmaceutically acceptable salts thereof |
| Assignee(s) | Jubilant Draximage Inc. |